JewelPUMP Insulin Delivery Platform with Smartphone Remote Control

JewelPUMP Insulin Delivery Platform with Smartphone Remote Control

Debiotech of Lausanne, Switzerland is bringing to the worldwide market its JewelPUMP insulin delivery device. The JewelPUMP carries 500 Units of insulin, providing a week’s worth use without having to change the pump (you’ll still have to replace the cannula patch every three days).

JewelCOM JewelPUMP Insulin Delivery Platform with Smartphone Remote ControlTo program the electronic patch, Debiotech developed their own Android powered phone, the JewelCOM, that features an integrated blood glucose meter. It uses dedicated SIM card security to communicate with the JewelPUMP, making it according to the company “the

most secure remotely controlled medical device ever conceived.” If you do misplace your phone, though, there are a couple buttons on the pump itself that you can use to deliver a bolus. Once you find the phone and it’s back within range of the pump, it will reprogram the delivery dosage as needed.

More from Severin Leven, PhD, lead of the JewelPUMP electronics team:

The communication between the JewelPUMP and the JewelCOM is using the new Bluetooth low energy mode and, thanks to the MEMS pump-chip, the JewelPUMP can operate for 7 days on a single green battery (mercury and lithium free). We have even incorporated a temperature sensor into the JewelPUMP to inform the patient in case the insulin would be over-exposed to heat. Last but not least, we have added a sensor to automatically detect any disconnection of the JewelPUMP from the cannula patch to automatically suspend the insulin delivery until it is reattached.

First Diabetes Clinical Study with the JewelPump™

(June 4, 2012)

Debiotech presents its new DIALEASETM system at EDTA-ERA in Paris

(May 21, 2012)

BRACCO Imaging acquires Debiotech’s subsidiary “Swiss Medical Care”.

(August 1, 2011)

JewelPUMP: “Best in show at ADA” says Diabetes Mine

(June 28th, 2010)

STMicroelectronics and Debiotech Debut Jewel Pump at ADA Congress,US

(June 23th, 2010)

Kimal Medical Systems introduces the Kimal IVantage infusion pump (June 1st, 2010)

Debiotech and EPFL receive the CTI Medtech Award 2008 in Bern

(September 2nd, 2008)

STMicroelectronics and Debiotech Announce First Prototypes of Disposable Insulin Nanopump.

(June 23th, 2008)

Gambro and Debiotech enter global partnership agreement in the area of Peritoneal Dialysis.

(March 19th, 2008)

Strategic agreement with STMicroelectronics regarding Debiotech’s

Insulin Nanopump

(April 19th, 2007)

Debiotech receives a Swiss Technology Award for its Renal Exprés

(March 1st, 2007)

CT Exprés III receives FDA clearance

(January 2nd, 2007)

Debiotech receives the Frost & Sullivan Enabling Technology 2006 Award

(November 13th, 2006)

Debiotech receives the Frost & Sullivan Entrepreneurial Company Award 2006

(July 7th, 2006)

Debiotech’s IV Pump receives the 2006 Medical Design Excellence Award

(April 10th, 2006)

Debiotech S.A. and EPFL in a collaborative alliance in the field of drug-eluting coatings.

(February 14th, 2006)

Debiotech receives a Swiss Technology Award 2006 and the Vontobel Prize

(January 27th, 2006)

IV Expres sales by Delphi Medical reach over $100 million in bookings

(December 7th, 2005)

Debioject® Reconstitution System to be used by Watson pharmaceuticals in the US

(April 29th, 2005)

Debiotech collaboration with EPFL on Dialysis

(November 29th, 2004)

Interview of Dr. Frederic Neftel, CEO of Debiotech, by the Wall street Reporter

(July 9th, 2004)

Debiotech announces license agreement with

DELPHI Medical Systems

(june 29th, 2004)

Debiotech receives the 2004 Medical Design Excellence Award (MDEA)

(june 16th, 2004)

Debiotech as “World Class” company in the Swiss financial HandelsZeitung

(june 9th, 2004)

Based on an ultra-miniaturized and highly precise MEMS pump

chip technology, developed and manufactured in partnership with

ST Microelectronics, the JewelPUMP is addressing still unmet needs

for diabetic patients.

“The JewelPUMP is the result of a tremendous effort to bring the

best of what advanced technology can offer for the benefit of the

patient, while complying with newly established regulatory

requirements for insulin pumps,” says Frédéric Neftel, MD, President

and CEO of DEBIOTECH SA. “We not only wanted to make the pump

really small, extremely safe and accurate, we also wanted to make

it really convenient to use while being concealed and so discreet

that you would forget you are under pump therapy. The results we

had the pleasure to present at the EASD are aligned with those

objectives thanks to an entirely new integrated platform of products

intended to fulfill diabetic patients needs and the latest regulatory

requirements. The comments and encouragements we received

from the large number of visitors we welcomed in our booth in

Berlin are certainly the greatest reward our

engineers and technicians could get for their intense work and

commitment to diabetes care.”

Source :

Related Posts Plugin for WordPress, Blogger...
Be Sociable, Share!

About the Author

has written 1822 posts on this blog.

Copyright © 2018 Medical Technology & Gadgets Blog All rights reserved.
Proudly powered by WordPress. Developed by Deluxe Themes